TheProfitWatch

KOD - Kodiak Sciences Inc Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
19.5 1.31 (6.72%) 0.0 (0.0%) -0.06 (-0.29%) -0.2 (-0.93%) 0.03 (0.15%) 1.35 (6.94%) 0.0 (0.0%) 0.03 (0.15%)

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.09
Diluted EPS:
-1.09
Basic P/E:
-19.0917
Diluted P/E:
-19.0917
RSI(14) 1m:
28.12
VWAP:
20.8
RVol:

Events

Period Kind Movement Occurred At

Related News